DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR PYRIDOSTIGMINE BROMIDE

« Back to Dashboard

All Clinical Trials for Pyridostigmine Bromide

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00953914	Pyridostigmine and Its Effects on Autonomic Modulation in Diabetic Patients	Completed	Hospital de Clinicas de Porto Alegre	N/A	2005-03-01	The purpose of the study is to determine if pyridostigmine bromide improves heart rate variability of type 2 diabetes mellitus subjects with cardiovascular autonomic neuropathy.
NCT01765140	Treatment Use of 3,4-Diaminopyridine	Available	Vern C. Juel, M.D.	N/A	1969-12-31	This is a continuing project to provide 3,4 diaminopyridine (DAP) under a treatment-use IND to patients with Lambert-Eaton myasthenic syndrome (LEMS) and congenital myasthenic syndrome (CMS).
NCT01855217	Pilot Study on the Pharmacodynamics of Sugammadex in Morbidly Obese Patients: Reversal of Deep Neuromuscular Blockade	Unknown status	St. Antonius Hospital	Phase 3	2013-04-01	Should the dose of sugammadex in morbid obese patients be calculated on the real body weight or the ideal body weight? To study the pharmacodynamics of sugammadex in morbidly obese patients by comparing 1 mg/kg IBW versus 1 mg/kg TBW versus placebo.

Clinical Trial Conditions for Pyridostigmine Bromide

Condition Name

Condition Name for Pyridostigmine Bromide
Intervention	Trials
Myasthenic Syndromes, Congenital	1
Gulf War Illness	1
Lambert Eaton Myasthenic Syndrome (LEMS)	1

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Pyridostigmine Bromide
Intervention	Trials
Acquired Immunodeficiency Syndrome	2
Infection	2
HIV Infections	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Pyridostigmine Bromide

Trials by Country

Trials by Country for Pyridostigmine Bromide
Location	Trials
United States	5
Mexico	2
Brazil	1
Switzerland	1
Netherlands	1

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Pyridostigmine Bromide
Location	Trials
North Carolina	2
Tennessee	1
New York	1
New Jersey	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Pyridostigmine Bromide

Clinical Trial Phase

Clinical Trial Phase for Pyridostigmine Bromide
Clinical Trial Phase	Trials
Phase 3	1
Phase 2/Phase 3	1
Phase 2	4

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Pyridostigmine Bromide
Clinical Trial Phase	Trials
Completed	2
Active, not recruiting	2
Recruiting	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Pyridostigmine Bromide

Sponsor Name

Sponsor Name for Pyridostigmine Bromide
Sponsor	Trials
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran	2
Vern C. Juel, M.D.	1
National Institutes of Health (NIH)	1

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Pyridostigmine Bromide
Sponsor	Trials
Other	9
NIH	2
U.S. Fed	1

Export unavailable in trial.
Subscribe for complete access.